Original Articles
Copyright ©2009 The WJG Press and Baishideng.
World J Gastroenterol. Jul 21, 2009; 15(27): 3367-3375
Published online Jul 21, 2009. doi: 10.3748/wjg.15.3367
Table 1 Grouping by MRI findings
Category 1Category 2Category 3Category 4
Mucosal enhancementNilMildMildMild or marked
Transmural enhancementNilNil or mildNil or mildMarked
Wall thickness (mm)> 3< 6> 6> 3
Table 2 Characteristics of the CD patients prior to the MRI examination
CD (n = 52)
Gender: male38.5% (20/52)
Age at diagnosis (yr)38.9 ± 16.0 (14-79)
A1 ≤ 1611.5% (6/52)
A2 17-4055.8% (29/52)
A3 > 4032.7% (17/52)
Crohn’s disease
L1 Terminal ileum78.8% (41/52)
L2 Colon0% (0/52)
L3 Ileocolonic19.2% (10/52)
L4 Upper GI7.7% (4/52)
P Perianal9.6% (5/52)
B1 Non-stricturing
Non-penetrating75.0% (39/52)
B2 Stricturing19.2% (10/52)
B3 Penetrating5.8% (3/52)
Colectomy11.5% (6/52)
Terminal ileal resection25.0% (13/52)
Proximal SB resection1.9% (1/52)
Table 3 MRI findings of patients according to the MRI category
MRI group (n)Male (%)Age (yr)Bowel length involved (cm)Wall thickness (mm)Degree of SB wall enhancementMucosal enhancement (%)Transmural enhancement (%)Mesenterichyperaemia (%)Fibrofatty proliferation (%)Regional lymph nodes (%)Free fluid (%)Narrowed lumen no hold-up (%)Prestenotic dilation ± holdup (%)Fistula (%)
1 (7)28.637.9 ± 9.46.3 ± 7.9< 3 0%None 100%00014.3014.357.114.30
(23-54)(1-25)3-6 71.4%Mild 0%
> 6 28.6%Marked 0%
2 (9)22.232.8 ± 9.213.8 ±12.3< 3 11.1%None 0%10088.933.333.366.633.344.4022.2
(17-78)(3-30)3-6 88.9%Mild 100%
> 6 0%Marked 0%
3 (16)43.840.1 ± 16.216.2 ± 12.0< 3 0%None 0%93.843.850.062.537.518.818.862.525.0
(14-79)(2-50)3-6 0%Mild 100%
> 6 100%Marked 0%
4 (20)45.041 ± 19.219.2 ± 11.6< 3 0%None 0%10090.075.075.085.035.035.035.020.0
(14-49)(2-45)3-6 10%Mild 0%
> 6 90%Marked 100%
Table 4 MRI category, medical therapy and clinical response (%)
MRI groupSteroids5ASAAntibioticsAZA/6MPMTXAnti-TNF αResponse
1 (n = 7)57.1057.1028.5085.700.0042.9014.30
2 (n = 9)55.5088.900.0022.2033.3044.40100.00
3 (n = 16)81.3068.806.3050.000.0012.5043.80
4 (n = 20)70.0070.005.0040.000.0035.0050.00
Responders (n = 27)63.0063.0011.1044.403.7025.90N/A
Non-responders (n = 25)76.0080.004.0048.008.0036.00N/A
Table 5 MRI category, response to medical therapy in relation to luminal narrowing with and without hold up
MRI groupNo narrowed lumenNarrowed lumen no hold upNarrowed lumen with hold up
1Response 0% (0/2)Response 25% (1/4)Response 0% (0/1)
n = 7No response 100% (2/2)No response 75% (3/4)No response 100% (1/1)
2Response 100% (5/5)Response 100% (4/4)Response N/A
n = 9No response 0% (0/5)No response 0% (0/4)No response N/A
3Response 66.7% (2/3)Response 66.7% (2/3)Response 40% (4/10)
n = 16No response 33.3% (1/3)No response 33.3% (1/3)No response 60% (6/10)
4Response 83.3% (5/6)Response 57.1% (4/7)Response 14.3% (1/7)
n = 20No response 16.7% (1/6)No response 42.9% (3/7)No response 85.7% (6/7)
TotalResponse 75.0% (12/16)Response 61.1% (11/18)Response 27.8% (5/18)
n = 52No response 25.0% (4/16)No response 38.9% (7/18)No response 72.2% (7/18)
Table 6 Correlation of MRI findings with surgical pathology
No.SexAgeMRI assessment
Surgical pathology
GroupFistulaInflammationFibrosisFistula
1F231NoMinimalYesNo
2M451NoNoYesNo
3F392YesMildNoYes
4M173NoMildYesNo
5F593NoMildYesNo
6F313NoMildYesNo
7M183NoModerateYesNo
8M243YesMildYesYes
9F373NoMildYesNo
10M413NoMildYesNo
11F624NoFloridYesNo
12M194NoFloridYesNo
13M614NoFloridYesNo
14F214YesFloridNoYes
15M434YesFloridYesYes
16M144NoFloridNoNo
17F564NoFloridNoNo